Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 276

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology

Open access
Deveson, Ira W., Gong, Binsheng, Lai, Kevin, LoCoco, Jennifer S., Richmond, Todd A., Schageman, Jeoffrey, Zhang, Zhihong, Novoradovskaya, Natalia, Willey, James C., Jones, Wendell, Kusko, Rebecca, Chen, Guangchun, Madala, Bindu Swapna, Blackburn, James, Stevanovski, Igor, Bhandari, Ambica, Close, Devin, Conroy, Jeffrey, Hubank, Michael, Marella, Narasimha, Mieczkowski, Piotr A., Qiu, Fujun, Sebra, Robert, Stetson, Daniel, Sun, Lihyun, Szankasi, Philippe, Tan, Haowen, Tang, Lin-ya, Arib, Hanane, Best, Hunter, Burgher, Blake, Bushel, Pierre R., Casey, Fergal, Cawley, Simon, Chang, Chia-Jung, Choi, Jonathan, Dinis, Jorge, Duncan, Daniel, Eterovic, Agda Karina, Feng, Liang, Ghosal, Abhisek, Giorda, Kristina, Glenn, Sean, Happe, Scott, Haseley, Nathan, Horvath, Kyle, Hung, Li-Yuan, Jarosz, Mirna, Kushwaha, Garima, Li, Dan, Li, Quan-Zhen, Li, Zhiguang, Liu, Liang-Chun, Liu, Zhichao, Ma, Charles, Mason, Christopher E., Megherbi, Dalila B., Morrison, Tom, Pabón-Peña, Carlos, Pirooznia, Mehdi, Proszek, Paula Z., Raymond, Amelia, Rindler, Paul, Ringler, Rebecca, Scherer, Andreas, Shaknovich, Rita, Shi, Tieliu, Smith, Melissa, Song, Ping, Strahl, Maya, Thodima, Venkat J., Tom, Nikola, Verma, Suman, Wang, Jiashi, Wu, Leihong, Xiao, Wenzhong, Xu, Chang, Yang, Mary, Zhang, Guangliang, Zhang, Sa, Zhang, Yilin, Shi, Leming, Tong, Weida, Johann, Donald J., Mercer, Timothy R., Xu, Joshua, SEQC2 Oncopanel Sequencing Working Group · 2021 · Nature Biotechnology

Abstract

Circulating tumor DNA (ctDNA) sequencing is being rapidly adopted in precision oncology, but the accuracy, sensitivity and reproducibility of ctDNA assays is poorly understood. Here we report the findings of a multi-site, cross-platform evaluation of the analytical performance of five industry-leading ctDNA assays. We evaluated each stage of the ctDNA sequencing workflow with simulations, synthetic DNA spike-in experiments and proficiency testing on standardized, cell-line-derived reference samples. Above 0.5% variant allele frequency, ctDNA mutations were detected with high sensitivity, precision and reproducibility by all five assays, whereas, below this limit, detection became unreliable and varied widely between assays, especially when input material was limited. Missed mutations (false negatives) were more common than erroneous candidates (false positives), indicating that the reliable sampling of rare ctDNA fragments is the key challenge for ctDNA assays. This comprehensive evaluation of the analytical performance of ctDNA assays serves to inform best practice guidelines and provides a resource for precision oncology. Reliable detection of mutations below 0.5% variant allele frequency remains a key challenge for circulating tumor DNA sequencing assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-021-00857-z

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 276

Metadata

Authors
Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T. A., Schageman, J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W., Kusko, R., Chen, G., Madala, B. S., Blackburn, J., Stevanovski, I., Bhandari, A., Close, D., Conroy, J., Hubank, M., Marella, N., Mieczkowski, P. A., Qiu, F., Sebra, R., Stetson, D., Sun, L., Szankasi, P., Tan, H., Tang, L.-Y., Arib, H., Best, H., Burgher, B., Bushel, P. R., Casey, F., Cawley, S., Chang, C.-J., Choi, J., Dinis, J., Duncan, D., Eterovic, A. K., Feng, L., Ghosal, A., Giorda, K., Glenn, S., Happe, S., Haseley, N., Horvath, K., Hung, L.-Y., Jarosz, M., Kushwaha, G., Li, D., Li, Q.-Z., Li, Z., Liu, L.-C., Liu, Z., Ma, C., Mason, C. E., Megherbi, D. B., Morrison, T., Pabón-Peña, C., Pirooznia, M., Proszek, P. Z., Raymond, A., Rindler, P., Ringler, R., Scherer, A., Shaknovich, R., Shi, T., Smith, M., Song, P., Strahl, M., Thodima, V. J., Tom, N., Verma, S., Wang, J., Wu, L., Xiao, W., Xu, C., Yang, M., Zhang, G., Zhang, S., Zhang, Y., Shi, L., Tong, W., Johann, D. J., Mercer, T. R., Xu, J., & SEQC2 Oncopanel Sequencing Working Group
Venue
Nature Biotechnology
Published
2021-04-12
Volume
39
Issue
9
Pages
1115-1128
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W3154855549
Cited by
276
References
56
FWCI
13.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. https://app.cochat.ai/papers/10.1038/s41587-021-00857-z
The paper
Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T. A., Schageman, J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W., Kusko, R., Chen, G., Madala, B. S., Blackburn, J., Stevanovski, I., Bhandari, A., Close, D., Conroy, J., Hubank, M., . . . SEQC2 Oncopanel Sequencing Working Group. (2021). Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nature Biotechnology. https://doi.org/10.1038/s41587-021-00857-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.